Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
3,940.30
-9.50 (-0.24%)
At close: Jan 13, 2026
Torrent Pharmaceuticals Revenue
Torrent Pharmaceuticals had revenue of 33.02B INR in the quarter ending September 30, 2025, with 14.30% growth. This brings the company's revenue in the last twelve months to 122.48B, up 9.13% year-over-year. In the fiscal year ending March 31, 2025, Torrent Pharmaceuticals had annual revenue of 115.16B with 7.35% growth.
Revenue (ttm)
122.48B
Revenue Growth
+9.13%
P/S Ratio
10.89
Revenue / Employee
7.18M
Employees
17,059
Market Cap
1.33T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 115.16B | 7.88B | 7.35% |
| Mar 31, 2024 | 107.28B | 11.08B | 11.51% |
| Mar 31, 2023 | 96.20B | 11.12B | 13.07% |
| Mar 31, 2022 | 85.08B | 5.03B | 6.29% |
| Mar 31, 2021 | 80.05B | 652.60M | 0.82% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Aurobindo Pharma | 325.14B |
| Cipla | 279.66B |
| Zydus Lifesciences | 244.94B |
| Apollo Hospitals Enterprise | 232.65B |
| Biocon | 164.76B |
| Alkem Laboratories | 138.90B |
| Mankind Pharma | 135.46B |
Torrent Pharmaceuticals News
- 8 days ago - Torrent Pharmaceuticals approves Rs 12,500 crore NCD issuance via private placement - Business Upturn
- 2 months ago - Torrent Pharmaceuticals Ltd (BOM:500420) Q2 2026 Earnings Call Highlights: Strong Revenue ... - GuruFocus
- 2 months ago - Torrent Pharmaceuticals shares rise over 4% today after strong Q2 earnings - Business Upturn
- 2 months ago - Q2 2026 Torrent Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus
- 4 months ago - Cybercrooks create fake website of pharma major to dupe investors - The Times of India
- 4 months ago - Torrent Pharma to acquire 26% stake in Torrent Urja 27 for renewable energy project in Gujarat - Business Upturn
- 5 months ago - Torrent Pharma’s Vizag plant clears USFDA inspection with zero observations - Business Upturn
- 6 months ago - Torrent Pharma Q1 net profit rises 20% on broad-based growth - The Times of India